August 23rd, 2011 by Elaine Schattner, M.D. in Opinion, Research
No Comments »

There’s so much weird and exciting cancer news this week, it’s hard to keep up!
Double-kudos to Andrew Pollack on his front-page and careful coverage in the New York Times of the hyperthermic intraperitoneal chemotherapy (Hipec) technique that’s being used at some name-brand health care facilities to treat colon cancer.
First, he spares no detail in the Times describing the seemingly primitive, crude method:
….For hours on a recent morning at the University of California, San Diego, Dr. Andrew Lowy painstakingly performed the therapy on a patient.
After slicing the man’s belly wide open, Read more »
*This blog post was originally published at Medical Lessons*
January 6th, 2010 by Bryan Vartabedian, M.D. in Better Health Network, Opinion
No Comments »

This was the year that Pharma disclosed the names and payments of their physician consultants. Look here for physicians speaking and consulting with Merck, GlaxoSmithKline, Lilly, and Pfizer.
Physician disclosure of conflict is important. It helps put a physician’s opinion and point of view into a context. Disclosure has long been the standard in the academic world. This represents the first time that such information has been made available to the general public.
But how will patients use this information and how will it affect care and outcomes? Should patients flatly avoid physicians or others who have a relationship with a pharmaceutical company? And should patients routinely screen physicians for conflict?
I don’t know the answer to these questions. I’m not sure patients know the answer to these questions. I suspect patients may not like the idea but would be willing to overlook a pharma connection when the reputation of the physician is impeccable.
Transparency is all the rage. Expect more. But I’m wondering how the average health consumer will practically process the information.

*This blog post was originally published at 33 Charts*
June 14th, 2009 by RamonaBatesMD in Better Health Network
1 Comment »

Recently the WSJ Health Blog posted “Should Doctors Say How Often They’ve Performed a Procedure?” written by Jacob Goldstein. It references another guest post by Adam Wolfberg, M.D — “Test Poses Challenge for OB-GYNs”
Dr. Wolfberg writes:
None of the published studies of CVS pitted seasoned physicians against novices; what patient would agree to be randomly assigned to an inexperienced doctor holding a long needle? But several reports from individual hospitals demonstrate that the miscarriage rate declined over time as the hospital’s staff became more experienced.
These reports point to a dilemma: CVS mavens got that way by practicing, so their present-day patients benefit at the expense of previous patients.
When I first began my solo practice 19 years ago, patients often asked how long I had been in practice. They ask less often these days. I have never failed to answer.
Patients sometimes ask how many times I have done a procedure, but not often. Early in my practice, and sometimes even now, if it is a procedure I feel a bit uneasy with or haven’t done in a while I will bring the subject up without being asked. After all, some procedures you just don’t do every day or even every month. Some diseases you don’t see every month or even every year.
In my mind, many of the procedures I do are built on basic surgical principles. I withdrew my privileges for microvascular procedures more than 10 years ago. I didn’t get enough patients referred to me to feel that my skills were kept sharp. In private practice, unlike at a university, there are no labs to go do practice work in to maintain those rarely used skills. I have no doubt that I could regain them given the chance, but at what cost (financially or complications).
Because I gave up my privileges for microvascular procedures, it means I have limited my repertoire of reconstructive procedures important in hand, breast, and other work. I tell my patients about them. If a breast reconstruction patient wants a free TRAM flap, then she is referred to someone who does it. If she wants to keep me as her surgeon, is there the possibility she is short changing herself on the outcome? I suppose, but I try (TRY) to be upfront and fair to each patient.
The question asked “should doctors say how often they’ve performed a procedure?” may seem an easy one to answer. If asked, yes. If not asked, should it be part of the consent form? I’m not sure it should for most procedures, but for extremely complex ones, maybe.
What if I did 100 of one type of procedure, but my last one was over a year ago? What if I have done 50 of a second procedure that is closely related in skill-set? What if that number is only 15? What if I have never done one and don’t wish to now, but the patient needs the procedure and is not willing to travel to another hospital? Is it okay that I have “informed” them, but they want to take the risk? How do I define that risk for them?
How many of which procedure is enough to become proficient? How often does it need to be done to remain proficient? Who gets to define proficient? Who gets to define the “magic” number of how many is enough to be proficient? Who get to define how often the procedure needs to be done to remain “proficient”?
As Dr Wolfberg noted
What patient would agree to be randomly assigned to an inexperienced doctor holding a long needle?
So how will these questions be answered?
*This blog post was originally published at Suture for a Living*